Decaux G, Dumont I, Waterlot Y, Hanson B
Nephron. 1985;39(3):164-8. doi: 10.1159/000183365.
Hypouricemia seen with hyponatremia related to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) results from an increase in uric acid renal clearance. We studied the mechanism of the increase of uric acid excretion in 6 SIADH patients through pyrazinamide (PZA), which decreases tubular secretion of uric acid, and sulfinpyrazone (SPZ) which decreases post-secretory reabsorption of uric acid. 3 g of PZA decreased the absolute uric acid excretion from 428 +/- 244 to 105 +/- 47 micrograms/min (mean +/- SD, p less than 0.01), and 300 mg of SPZ increased the uric acid to creatinine clearance ratio from 0.31 +/- 0.05 to 0.52 +/- 0.05 mg/dl glomerular filtration rate (mean +/- SEM, p less than 0.001), which represent an increment about half of that observed in the control group. The increase of uric acid clearance in SIADH seems to result from a decrease in the post-secretory reabsorption of uric acid. After SPZ, we saw a decrease of natriuresis from 5.6 +/- 1.4 to 1.8 +/- 0.3 mmol/h (p less than 0.001), without any change of urinary flow or urinary potassium excretion.
抗利尿激素分泌不当综合征(SIADH)相关的低钠血症伴发的低尿酸血症是由尿酸肾清除率增加所致。我们通过使用可减少尿酸肾小管分泌的吡嗪酰胺(PZA)和可减少尿酸分泌后重吸收的磺吡酮(SPZ),研究了6例SIADH患者尿酸排泄增加的机制。3克PZA使尿酸绝对排泄量从428±244微克/分钟降至105±47微克/分钟(平均值±标准差,p<0.01),300毫克SPZ使尿酸与肌酐清除率比值从0.31±0.05升至0.52±0.05毫克/分升肾小球滤过率(平均值±标准误,p<0.001),这一增幅约为对照组观察值的一半。SIADH中尿酸清除率的增加似乎是由于尿酸分泌后重吸收减少所致。使用SPZ后,我们观察到利钠作用从5.6±1.4降至1.8±0.3毫摩尔/小时(p<0.001),而尿流或尿钾排泄无任何变化。